Table 2.

Functional CTL activity of in vitro expanded cells correlates with tetrameric Mamu-A*01/p11C, C-M complex binding to CD8+ T cells in different secondary lymphoid compartments of SIVmac-infected, Mamu-A*01+ rhesus monkeys

MonkeySpleenMesenteric lymph nodePBL
Freshp11C, C-M*expandedFreshp11C, C-M expandedFreshp11C, C-M expanded
% tetramer% tetramer% lysis (5/3/1)% tetramer% tetramer% lysis (5/3/1)% tetramer% tetramer% lysis (5/3/1)
575 8.7 8.32-153 29/21/152-153 2.7 28.8 34/25/15 5.3 18.3 14/9/5 
3KI 3.0 49.0 55/50/40 2.8 43.9 57/51/40 1.3 61.3 67/67/60 
IPI 9.4 49.8 55/54/36 7.7 69.5 58/52/46 6.0 69.5 55/53/45 
297 11.7 19.5 18/12/6 6.2 6.5 18/14/7 6.2 50.3 51/42/31 
MonkeySpleenMesenteric lymph nodePBL
Freshp11C, C-M*expandedFreshp11C, C-M expandedFreshp11C, C-M expanded
% tetramer% tetramer% lysis (5/3/1)% tetramer% tetramer% lysis (5/3/1)% tetramer% tetramer% lysis (5/3/1)
575 8.7 8.32-153 29/21/152-153 2.7 28.8 34/25/15 5.3 18.3 14/9/5 
3KI 3.0 49.0 55/50/40 2.8 43.9 57/51/40 1.3 61.3 67/67/60 
IPI 9.4 49.8 55/54/36 7.7 69.5 58/52/46 6.0 69.5 55/53/45 
297 11.7 19.5 18/12/6 6.2 6.5 18/14/7 6.2 50.3 51/42/31 
*

p11C, C-M represents the 9-amino acid fragment optimal epitope of the SIV Gag 12-amino acid peptide p11C.

E:T ratios.

Percent staining of tetrameric Mamu-A*01/p11C, C-M complex on CD8+ T cells. CD8+ T cells are defined by gating on CD8αβ+ CD3+ cells.

F2-153

Percent p11C, C-M-specific lysis was calculated as percent specific release by p11C, C-M-pulsed Mamu-A*01+ target cells minus the percent specific release by control peptide p11B-pulsedMamu-A*01+ target cells.

or Create an Account

Close Modal
Close Modal